Top compounds associated with response to ACAT2


Feature Type Standardized
Nominal ANOVA
mRNA Bosutinib FIMM pan-cancer AAC -0.41 0.2
mRNA Erlotinib UHNBreast pan-cancer AAC -0.4 0.2
mRNA 17-AAG FIMM pan-cancer AAC -0.34 0.07
mRNA serdemetan FIMM pan-cancer AAC -0.33 0.05
mRNA lenalidomide FIMM pan-cancer AAC -0.32 0.07
mRNA SR8278 CTRPv2 pan-cancer AAC -0.32 0.02
mRNA Tipifarnib FIMM pan-cancer AAC -0.31 0.02
mRNA AZD-2281 FIMM pan-cancer AAC -0.3 0.09
mRNA Bicalutamide FIMM pan-cancer AAC -0.3 0.1
mRNA Imatinib FIMM pan-cancer AAC -0.27 0.2
Download CSV